http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2207218-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57c0de0495d0db0bd8baec9a569d76c5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2984 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1274 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate | 1995-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4baa7c585cf38a490d932441bd6220f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9999b5db3f63226be09c9ec6c165441 |
| publicationDate | 2002-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2207218-C |
| titleOfInvention | Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure |
| abstract | A controlled-release composition for a biologically active material, characterized in that it comprises a mixture of: a) monocaproin, optionally in admixture with monocaprylin and/or monocaprin, and b) a polar liquid selected from the group consisting of such polar liquids which are capable of forming an L2 phase with a), and c) a biologically active material dissolved or dispersed in said mixture of a) and b), a) being present in the composition, based on the total weight of a) + b), in an amount of from the lower limit where the mixture of a) and b) forms a reversed micellar (L2) structure and up to 100 % by weight of a), with the further proviso that said mixture of a) and b) is essentially within that specific domain of the L2 structure, in a phase diagram, where said L2 structure will change to a normal micellar (L1) structure if contacted with an external polar liquid. Said composition is preferably used as a medical composition. |
| priorityDate | 1994-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.